Over 20,000 business participants

Company Information

Company Immune Therapeutics, Inc.
www.immunetherapeutics.com
Type:
SME
Country:
United States of America
Ownership:
Publicly Listed
Global Compact Status:
Delisted
Reason for Delisting:
Expelled due to failure to communicate progress
Participant Since
16 March 2015
Letter of Commitment
Next Communication on Progress (COP) due on:
16 March 2019

Financial Information